Inhibitors of human immunodeficiency virus replication

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10954252
SERIAL NO

16606345

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIIV HEALTHCARE UK (NO 5) LIMITEDSTEVENAGE SG1 2NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Babu, Suresh Bangalore, IN 34 404
Belema, Makonen Wallingford, US 73 1671
Bender, John A Wallingford, US 66 917
Iwuagwu, Christiana Wallingford, US 18 10
Kadow, John F Branford, US 185 1556
Kumaravel, Selvakumar Bangalore, IN 8 30
Nagalakshmi, Pulicharla Bangalore, IN 9 33
Naidu, B Narasimhulu Branford, US 77 382
Patel, Manoj Wallingford, US 51 188
Peese, Kevin M Branford, US 14 61
Rajamani, Ramkumar Wallingford, US 27 93
Saulnier, Mark Wallingford, US 1 0
Wang, Alan Xiangdong Wallingford, US 28 260

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 23, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 23, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00